Camber Pharma Discontinues Products

Piscataway, NJ, March 3, 2016– Effec1ve February 28, 2016 Camber Pharmaceu1cals’parent company, Hetero Drugs, has sold some of their product line to Cipla Ltd. of Mumbai India.  For a list of the discon1nued products please visit our Products Page.

Kon Ostaficiuk, President of Camber commented, “First and foremost we want to reassure you that Camber’s commitment to its customers to deliver the highest quality generic pharmaceu1cals and provide excellence in service, supply and affordability has never been stronger.”

“This sale, a historic milestone for Hetero and Camber, will provide us with an unprecedented opportunity to invest in state-of-the-art facili1es and new ANDA’s which will help take Camber to the next level as an organiza1on.” Ostaficiuk con1nues, “We are planning an aggressive launch schedule that will see us introduce some 30 new products each year for the next two years which will quickly replenish our portfolio.”

If you would like more informa1on about this topic, please contact Megan Becker at 732.529.0436 or email at mbecker@camberpharma.com.